(NASDAQ: PEPG) Pepgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 87.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.
Pepgen's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PEPG's revenue for 2027 to be $504,459,755, with the lowest PEPG revenue forecast at $504,459,755, and the highest PEPG revenue forecast at $504,459,755. On average, 1 Wall Street analysts forecast PEPG's revenue for 2028 to be $1,782,337,002, with the lowest PEPG revenue forecast at $1,782,337,002, and the highest PEPG revenue forecast at $1,782,337,002.
In 2029, PEPG is forecast to generate $4,345,143,437 in revenue, with the lowest revenue forecast at $4,007,798,276 and the highest revenue forecast at $4,682,488,598.